Continuous subcutaneous levodopa/ carbidopa infusion for Parkinson's disease: 3-year data from the BeyoND study

被引:0
作者
Poewe, W. [1 ]
Stocchi, F. [2 ]
Adar, L. [3 ]
Sopromadze, S. [3 ]
Yardeni, T. [3 ]
Giladi, N. [4 ]
机构
[1] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria
[2] Univ & Inst Res & Med Care, IRCCS San Raffaele, Rome, Italy
[3] NeuroDerm Ltd, Rehovot, Israel
[4] Tel Aviv Univ, Neurol Inst, Sagol Sch Neurosci, Sackler Sch Med,Tel Aviv Med Ctr, Tel Aviv, Israel
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPR-282
引用
收藏
页码:313 / 313
页数:1
相关论文
共 50 条
[41]   Levodopa Carbidopa Infusion Gel to Treat Very Advanced idiopathic Parkinson's disease [J].
Aldred, Jason ;
Bergeleen, Anne .
NEUROLOGY, 2016, 86
[42]   Pharmacokinetic profile of ND0612L (levodopa/carbidopa for subcutaneous infusion) in patients with moderate to severe Parkinson's disease [J].
Giladi, N. ;
Caraco, Y. ;
Gurevich, T. ;
Djaldetti, R. ;
Cohen, Y. ;
Yacobi-Zeevi, O. ;
Oren, S. .
MOVEMENT DISORDERS, 2015, 30 :S87-S88
[43]   Management of complications related to intraduodenal infusion of levodopa/carbidopa in patients with Parkinson's disease [J].
Santos-Garcia, Diego ;
de Deus, Teresa ;
Lopez-Pazos, Elina ;
Macias-Arribi, Mercedes ;
Llaneza-Gonzalez, Miguel A. ;
Echarri-Piudo, Ana ;
Carpintero, Pedro ;
de la Fuente-Fernandez, Raul .
REVISTA DE NEUROLOGIA, 2014, 58 (11) :505-515
[44]   Levodopa-entacapone-carbidopa intestinal gel infusion for advanced Parkinson's disease patients - data from a Romanian center [J].
Dulamea, A. ;
Barbulescu, T. ;
Banica, C. .
MOVEMENT DISORDERS, 2022, 37 :S446-S446
[45]   Continuous intestinal infusion of levodopa-carbidopa in patients with advanced Parkinson's disease in Spain: Subanalysis by autonomous community [J].
Santos-Garcia, D. ;
Catalan, M. J. ;
Puente, V ;
Valldeoriola, F. ;
Regidor, I ;
Mir, P. ;
Matias-Arbelo, J. ;
Parra, J. C. ;
Grandas, F. .
NEUROLOGIA, 2021, 36 (02) :101-111
[46]   Levodopa-entacapone-carbidopa intestinal gel infusion for Parkinson's disease: An analysis of data collected from the Swedish national register of Parkinson's disease. [J].
Othman, M. ;
Odin, P. ;
Bergquist, F. ;
Johansson, A. ;
Constantinescu, R. ;
Scharfenort, M. ;
Widner, H. ;
Nyholm, D. .
MOVEMENT DISORDERS, 2023, 38 :S618-S618
[47]   THE ROLE OF THE GASTROENTEROLOGIST IN ADVANCED PARKINSON'S DISEASE: CONTINUOUS INFUSION OF LEVODOPA-CARBIDOPA BY PEG-J TUBE [J].
Apicella, I. ;
De Mase, A. ;
Ormando, V. M. ;
De Micco, R. ;
Ferraro, F. ;
Tessitore, A. ;
Romano, M. ;
Esposito, P. .
DIGESTIVE AND LIVER DISEASE, 2017, 49 :E81-E81
[48]   Effectiveness and safety of levodopa-entacapone-carbidopa infusion in Parkinson disease: A real-world data study [J].
Santos-Garcia, Diego ;
Lopez-Manzanares, Lydia ;
Muro, Ines ;
Lorenzo-Barreto, Pablo ;
Casas Pena, Elena ;
Garcia-Ramos, Rocio ;
Fernandez Valle, Tamara ;
Morata-Martinez, Carlos ;
Baviera-Munoz, Raquel ;
Martinez-Torres, Irene ;
Alvarez-Sauco, Maria ;
Alonso-Modino, Deborah ;
Legarda, Ines ;
Valero-Garcia, Maria Fuensanta ;
Suarez-Munoz, Jose Andres ;
Martinez-Castrillo, Juan Carlos ;
Perona, Ana Belen ;
Salom, Jose Maria ;
Cubo, Esther ;
Valero-Merino, Caridad ;
Lopez-Ariztegui, Nuria ;
Sanchez Alonso, Pilar ;
Novo Ponte, Sabela ;
Gamo Gonzalez, Elisa ;
Martin Garcia, Raquel ;
Espinosa, Raul ;
Carmona, Mar ;
Feliz, Cici Esmerali ;
Garcia Ruiz, Pedro ;
Munoz Ruiz, Teresa ;
Fernandez Rodriguez, Beatriz ;
Mata, Marina .
EUROPEAN JOURNAL OF NEUROLOGY, 2025, 32 (01)
[49]   Long-term safety of continuous levodopa/carbidopa infusion with ND0612: Data from patients who continued past one year in the BeyoND study [J].
Isaacson, S. ;
Giladi, N. ;
Stocchi, F. ;
Salin, L. ;
Vostokova, N. ;
Poewe, W. .
MOVEMENT DISORDERS, 2022, 37 :S334-S334
[50]   Levodopa-Entacapone-Carbidopa Intrajejunal Infusion in Advanced Parkinson's Disease - Interim Analysis of the ELEGANCE Study [J].
Weiss, Daniel ;
Jost, Wolfgang H. ;
Szasz, Jozsef Attila ;
Pirtosek, Zvezdan ;
Milanov, Ivan ;
Tomantschger, Volker ;
Kovacs, Norbert ;
Staines, Harry ;
Amlani, Bharat ;
Smith, Niall ;
van Laar, Teus .
MOVEMENT DISORDERS CLINICAL PRACTICE, 2025,